Delivery Order SPE2DB22D6029-SPE2DB25FLTTP

Award Date 1/21/25
Potential Completion Date 1/22/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,336.15 firm fixed-price delivery order is for DALVANCE 500 MG VIALS and has a completion date of December 18, 2024. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,356.61 firm fixed-price delivery order is for the supply of DALVANCE 500 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of November 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,605.90 firm fixed price delivery order is for the supply of DALVANCE 500 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of August 31, 2022 and was awarded on August 30, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides the delivery of DALVANCE 500 MG VIALS medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The $14,099.17 firm fixed price delivery order contract has an ultimate completion date of October 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $21,185.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DALVANCE 500 MG VIALS, a medical product, with a completion date of February 6, 2025. The contract is a delivery order, with a firm fixed price pricing type, and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp (AmerisourceBergen) is for the delivery of DALVANCE 500 MG VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $14,840.30 fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award, valued at $13,511.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of DALVANCE 500 MG VIALS, with a period of performance extending through January 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4566927993 units of the drug DALVANCE 500 MG VIALS. The $17,929.01 contract is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of January 15, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,688.81 firm fixed-price delivery order is for the supply of DALVANCE 500 MG vials, a specialty pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is for the delivery of DALVANCE 500 MG VIALS to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $2,688.84 and has an ultimate completion date of January 13, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB25FLTTP
    Delivery Order

This federal contract award, with ID SPE2DB22D6029|SPE2DB25FLTTP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,792.56 firm fixed-price delivery order is for the supply of 4566987527 DALVANCE 500 MG VIALS. This contract is not designated as a set-aside.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 4/22/25, 11:50 AM